Suppr超能文献

继发性V(D)J重组在致癌性染色体易位中起作用吗?

A role for secondary V(D)J recombination in oncogenic chromosomal translocations?

作者信息

Davila M, Foster S, Kelsoe G, Yang K

机构信息

Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Adv Cancer Res. 2001;81:61-92. doi: 10.1016/s0065-230x(01)81002-2.

Abstract

Chromosomal translocations are hallmarks of certain lymphoproliferative disorders. Indeed, in many leukemias and lymphomas, translocations are the transforming event that brings about malignancy. Recurrence of the immunoglobulin (Ig) and T-cell receptor (Tcr) loci at the breakpoints of oncogenic chromosomal translocations has led to speculation that the lymphocyte-specific process of V(D)J rearrangement, which is necessary for the generation of functional Ig and TCR antigen receptors on B and T lymphocytes, mediates translocation. Recent studies have led to a fuller understanding of the molecular mechanisms of V(D)J rearrangement and have revealed that the V(D)J recombinase possesses latent transposase activity. These studies have led to plausible models of illegitimate V(D)J recombination producing chromosomal translocations consistent with those present in lymphomas and leukemias. Errors of V(D)J recombination may even generate lymphomas with the phenotypes of mature cells. For example, follicular and Burkitt's lymphomas have been classified by phenotype and somatic genotype as malignant germinal center (GC) B or post-GC B cells. The GC is a site of affinity maturation where B cells undergo V(D)J hypermutation and Ig class switch; in addition, much evidence has accumulated to suggest that GC B cells may also support secondary V(D)J recombination. Interestingly, all three of these elements, genomic plasticity, mutation, and translocation breakpoints near switch sites or recombinational elements, are characteristic of certain lymphomas. The high frequency of lymphomas carrying these GC markers suggests that the GC reaction may play a significant role in lymphomagenesis.

摘要

染色体易位是某些淋巴细胞增殖性疾病的标志。事实上,在许多白血病和淋巴瘤中,易位是导致恶性肿瘤发生的转化事件。致癌性染色体易位断点处免疫球蛋白(Ig)和T细胞受体(Tcr)基因座的反复出现,引发了这样的推测:V(D)J重排这一淋巴细胞特异性过程介导了易位,而V(D)J重排是B淋巴细胞和T淋巴细胞上功能性Ig和TCR抗原受体产生所必需的。最近的研究使我们对V(D)J重排的分子机制有了更全面的了解,并揭示V(D)J重组酶具有潜在的转座酶活性。这些研究得出了似是而非的非法V(D)J重组产生染色体易位的模型,这些易位与淋巴瘤和白血病中存在的易位一致。V(D)J重排错误甚至可能产生具有成熟细胞表型的淋巴瘤。例如,滤泡性淋巴瘤和伯基特淋巴瘤已根据表型和体细胞基因型被分类为恶性生发中心(GC)B细胞或GC后B细胞。GC是亲和力成熟的场所,B细胞在其中经历V(D)J超突变和Ig类别转换;此外,大量证据表明GC B细胞也可能支持继发性V(D)J重组。有趣的是,基因组可塑性、突变以及靠近转换位点或重组元件的易位断点这三个因素,都是某些淋巴瘤的特征。携带这些GC标志物的淋巴瘤的高频率表明GC反应可能在淋巴瘤发生中起重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验